Genetic determinants of osteoporosis: Common bases to cardiovascular diseases?

International Journal of Hypertension

Volumn 2010, Issue , 2010, Pages

  Marini, Francesca ^a   Brandi, Maria Luisa ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AROMATASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN 2; CALCITONIN RECEPTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA1; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; OSTEOPROTEGERIN; PARATHYROID HORMONE RECEPTOR; RALOXIFENE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

AR GENE; ARTICLE; BMP2 GENE; BONE DENSITY; BONE METABOLISM; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CASR GENE; COLI1A1 GENE; CTR GENE; CYP19A1 GENE; DISEASE ASSOCIATION; DISEASE MODEL; DYSLIPIDEMIA; FRACTURE; FRAGILITY FRACTURE; GENE; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; IGF 1 GENE; IL 6 GENE; LIFESTYLE; LRP5 GENE; LRP6 GENE; NONHUMAN; NUTRITION; OPG GENE; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHARMACOGENETICS; PRIORITY JOURNAL; PTHR1 GENE; RECEPTOR GENE; RISK ASSESSMENT; RISK REDUCTION; SOST GENE; TGFBETA1 GENE;

EID: 79961143101     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2010/394579     Document Type: Article

References (158)

1. Krall E. A., Dawson-Hughes B., Heritable and life-style determinants of bone mineral density. Journal of Bone and Mineral Research 1993 8 1 1 9 2-s2.0-0027492067 (Pubitemid 23033990)
2. Guéguen R., Jouanny P., Guillemin F., Kuntz C., Pourel J., Siest G., Segregation analysis and variance components analysis of bone mineral density in healthy families. Journal of Bone and Mineral Research 1995 10 12 2017 2022 2-s2.0-0028866916
3. Stewart T. L., Ralston S. H., Role of genetic factors in the pathogenesis of osteoporosis. Journal of Endocrinology 2000 166 2 235 245 2-s2.0-0033838929 (Pubitemid 30650561)
4. Deng H.-W., Chen W.-M., Recker S., Genetic determination of Colles fracture and differential bone mass in women with and without Colles fracture. Journal of Bone and Mineral Research 2000 15 7 1243 1252 2-s2.0-0034047682 (Pubitemid 30413856)
5. Andrew T., toby.andrew@kcl.ac.uk Antioniades L., Scurrah K. J., MacGregor A. J., Spector T. D., Risk of wrist fracture in women is heritable and is influenced by genes that are largely independent of those influencing BMD. Journal of Bone and Mineral Research 2005 20 1 67 74 2-s2.0-0037739951 10.1359/jbmr.2005.20.1.67 (Pubitemid 41716220)
6. Arden N. K., Baker J., Hogg C., Baan K., Spector T. D., The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. Journal of Bone and Mineral Research 1996 11 4 530 534 2-s2.0-0029922240 (Pubitemid 26109073)
7. Garnero P., Arden N. K., Griffiths G., Delmas P. D., Spector T. D., Genetic influence on bone turnover in postmenopausal twins. Journal of Clinical Endocrinology and Metabolism 1996 81 1 140 146 10.1210/jc.81.1.140 2-s2.0-0030023889 (Pubitemid 26035015)
8. Morishima A., Grumbach M. M., Simpson E. R., Fisher C., Qin K., Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 1995 80 12 3689 3698 2-s2.0-0028792229
9. Smith E. P., Boyd J., Frank G. R., Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. The New England Journal of Medicine 1994 331 16 1056 1061 2-s2.0-0028143234 10.1056/NEJM199410203311604 (Pubitemid 24317698)
10. Barros E. R., Dias da Silva M. R., Kunii I. S., Hauache O. M., Lazaretti-Castro M., A novel mutation in the LRP5 gene is associated with osteoporosis-pseudoglioma syndrome. Osteoporosis International 2007 18 7 1017 1018 10.1007/s00198-007-0360-x 2-s2.0-34249985294 (Pubitemid 46889561)
11. Carbonell Sala S., Masi L., Marini F., Genetics and pharmacogenetics of osteoporosis. Journal of Endocrinological Investigation 2005 28 supplement 10 2 7 2-s2.0-33645826023
12. Carbonell Sala S., Brandi M. L., Genetic determinants of osteoporosis. Medicografia 2007 29 180 184
13. Ralston S. H., stuart.ralston@ed.ac.uk Genetics of osteoporosis: symposium on 'genetic polymorphisms and disease risk' Proceedings of the Nutrition Society 2007 66 2 158 165 2-s2.0-0030064183 10.1017/S002966510700540X (Pubitemid 46684969)
14. Williams F. M. K., Spector T. D., Recent advances in the genetics of osteoporosis. Journal of Musculoskeletal Neuronal Interactions 2006 6 1 27 35 2-s2.0-33646712380 (Pubitemid 43732826)
15. Andrew T., Macgregor A. J., Genes and osteoporosis. Current Osteoporosis Reports 2004 2 3 79 89 10.1007/s11914-004-0015-1 2-s2.0-23944501360
16. Pennisi P., Signorelli S. S., Riccobene S., Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporosis International 2004 15 5 389 395 10.1007/s00198-003-1550-9 2-s2.0-2442566636 (Pubitemid 38639334)
17. Kiel D. P., Kauppila L. I., Cupples L. A., Hannan M. T., ODonnell C. J., Wilson P. W. F., Bone loss and the progression of abdominal aortic calcification over 25 year period: the Framingham Heart Study. Calcified Tissue International 2001 68 5 271 276 2-s2.0-0034973385 (Pubitemid 32565728)
18. von der Recke P., Hansen M. A., Hassager C., The association between low bone mass at the menopause and cardiovascular mortality. American Journal of Medicine 1999 106 3 273 278 10.1016/S0002-9343(99)00028-5 2-s2.0-0033105456 (Pubitemid 29153403)
19. Marcovitz P. A., Tran H. H., Franklin B. A., Usefulness of bone mineral density to predict significant coronary artery disease. American Journal of Cardiology 2005 96 8 1059 1063 10.1016/j.amjcard.2005.06.034 2-s2.0-26244464885 (Pubitemid 41416595)
20. Collin-Osdoby P., Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circulation Research 2004 95 11 1046 1057 10.1161/01.RES.0000149165.99974.12 2-s2.0-9344246863 (Pubitemid 39557891)
21. Ikeda F., Nishimura R., Matsubara T., Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-requlated osteoclast differentiation. Journal of Clinical Investigation 2004 114 4 475 484 10.1172/JCI200419657 2-s2.0-4344697340 (Pubitemid 39572097)
22. McFarlane S. I., Muniyappa R., Shin J. J., Bahtiyar G., Sowers J. R., Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 2004 23 1 1 10 2-s2.0-2442540370 (Pubitemid 38621633)
23. Yamaguchi T., Sugimoto T., Yano S., Plasma lipids and osteoporosis in postmenopausal women. Endocrine Journal 2002 49 2 211 217 2-s2.0-0036252175 (Pubitemid 34496340)
24. Strazzullo P., Nunziata V., Cirillo M., Abnormalities of calcium metabolism in essential hypertension. Clinical Science 1983 65 2 137 141 2-s2.0-0020617515 (Pubitemid 13054477)
25. Cappuccio F. P., Meilahn E., Zmuda J. M., Cauley J. A., High blood pressure and bone-mineral loss in elderly white women: a prospective study. The Lancet 1999 354 9183 971 975 10.1016/S0140-6736(99)01437-3 2-s2.0-0033581448 (Pubitemid 29438401)
26. Hvarfner A., Bergström R., Mörlin C., Wide L., Ljunghall S., Relationships between calcium metabolic indices and blood pressure in patients with essential hypertension as compared with a healthy population. Journal of Hypertension 1987 5 4 451 456 2-s2.0-0023238931 (Pubitemid 17126234)
27. Izawa Y., Sagara K., Kadota T., Makita T., Bone disorders in spontaneously hypertensive rat. Calcified Tissue International 1985 37 6 605 607 2-s2.0-0022368578 (Pubitemid 16197168)
28. Cirillo M., Galetti F., Strazzullo P., Torielli L., Melloni M. C., On the pathogenetic mechanism of hypercalciuria in genetically hypertensive rats of the Milan strain. American Journal of Hypertension 1989 2 10 741 746 2-s2.0-0024470407 (Pubitemid 19242109)
29. Grobbee D. E., Burger H., Hofman A., Pols H. A., Blood pressure and bone density are inversely related in the elderly. Journal of Hypertension 1996 14 supplement 11 S35
30. Tsuda J., Nishio I., Masuyama Y., Is hypertension a risk factor for osteoporosis? Dual energy X-ray absorptiometric investigation. Journal of Hypertension 1998 16 supplement 2 S209
31. Baldini V., Mastropasqua M., Francucci C. M., DErasmo E., Cardiovascular disease and osteoporosis. Journal of Endocrinological Investigation 2005 28 supplement 10 69 72 2-s2.0-33645808431
32. Burnett J. R., Vasikaran S. D., Cardiovascular disease and osteoporosis: is there a link between lipids and bone? Annals of Clinical Biochemistry 2002 39 3 203 210 10.1258/0004563021902134 2-s2.0-0036264588 (Pubitemid 34494209)
33. Danilevicius C. F., Lopes J. B., Pereira R. M. R., Bone metabolism and vascular calcification. Brazilian Journal of Medical and Biological Research 2007 40 4 435 442 2-s2.0-34247187567 (Pubitemid 46605016)
34. Price P. A., Faus S. A., Williamson M. K., Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 5 817 824 2-s2.0-0035036363 (Pubitemid 32448773)
35. Walsh B. W., Kuller L. H., Wild R. A., Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. Journal of the American Medical Association 1998 279 18 1445 1451 10.1001/jama.279.18.1445 2-s2.0-2642712522 (Pubitemid 28228201)
36. Saitta A., Altavilla D., Cucinotta D., Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 9 1512 1519 2-s2.0-0035572888 (Pubitemid 34219817)
37. Barrett-Connor E., Grady D., Sashegyi A., Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. Journal of the American Medical Association 2002 287 7 847 857 2-s2.0-0037138787 (Pubitemid 34252031)
38. Mundy G., Garrett R., Harris S., Stimulation of bone formation in vitro and in rodents by statins. Science 1999 286 5446 1946 1949 10.1126/science.286. 5446.1946 2-s2.0-0033521078 (Pubitemid 129515901)
39. Edwards C. J., Hart D. J., Spector T. D., Oral statins and increased bone-mineral density in postmenopausal women. The Lancet 2000 355 9222 2218 2219 2-s2.0-0034709764 (Pubitemid 30394332)
40. Lynn H., Kwok T., Wong S. Y. S., Woo J., Leung P. C., Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 2006 38 4 584 588 10.1016/j.bone.2005.09.011 2-s2.0-33644979330
41. Izu Y., Mizoguchi F., Kawamata A., Angiotensin II type 2 receptor blockade increases bone mass. Journal of Biological Chemistry 2009 284 8 4857 4864 10.1074/jbc.M807610200 2-s2.0-64149118080
42. Iijima K., ARB and anti-aging Nippon Rinsho 2009 67 826 834
43. Morrison N. A., Qi J. C., Tokita A., Prediction of bone density from vitamin D receptor alleles. Nature 1994 367 6460 284 287 10.1038/367284a0 2-s2.0-23444460542 (Pubitemid 24051146)
44. Thakkinstian A., DEste C., Eisman J., Nguyen T., Attia J., Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. Journal of Bone and Mineral Research 2004 19 3 419 428 10.1359/JBMR.0301265 2-s2.0-2942756199 (Pubitemid 38787397)
45. Uitterlinden A. G., Ralston S. H., Brandi M. L., The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Annals of Internal Medicine 2006 145 4 255 264 2-s2.0-33747115419 (Pubitemid 46768609)
46. Van Schooten F. J., Hirvonen A., Maas L. M., Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human fight atrial tissue. FASEB Journal 1998 12 13 1409 1417 2-s2.0-0031717255 (Pubitemid 28475583)
47. Scragg R., Jackson R., Holdaway I. M., Lim T., Beaglehole R., Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. International Journal of Epidemiology 1990 19 3 559 563 2-s2.0-0025094254 (Pubitemid 20331800)
48. Stamler J., Wentworth D., Neaton J. D., Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?. Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). Journal of the American Medical Association 1986 256 20 2823 2828 2-s2.0-0023025526 (Pubitemid 17178359)
49. Pan X.-M., Li D.-R., Yang L., No association between Vitamin D receptor polymorphisms and coronary artery disease in a Chinese population. DNA and Cell Biology 2009 28 10 521 525 10.1089/dna.2009.0908 2-s2.0-70349469817
50. Ioannidis J. P. A., Stavrou I., Trikalinos T. A., Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. Journal of Bone and Mineral Research 2002 17 11 2048 2060 2-s2.0-0036829250 (Pubitemid 35239206)
51. van Meurs J. B. J., Schuit S. C. E., Well A. E. A. M., Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Human Molecular Genetics 2003 12 14 1745 1754 10.1093/hmg/ddg176 2-s2.0-0041808714 (Pubitemid 36896666)
52. Ioannidis J. P. A., Ralston S. H., Bennett S. T., Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. Journal of the American Medical Association 2004 292 17 2105 2114 10.1001/jama.292.17.2105 2-s2.0-7244234185 (Pubitemid 39435101)
53. Cepollaro C., Lauretani F., Gozzini A., Relationship of volumetric bone mineral density and structural parameters with ERa gene polymorphisms. Calcified Tissue International 2007 80 5 307 315 10.1007/s00223-007-9008-2 2-s2.0-34250214524 (Pubitemid 46897443)
54. Windahl S. H., Vidal O., Andersson G., Gustafsson J. A., Ohlsson C., Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERβ-/- mice. Journal of Clinical Investigation 1999 104 7 895 901 2-s2.0-0032748023 (Pubitemid 29536339)
55. Ogawa S., Hosoi T., Shiraki M., Association of estrogen receptor β gene polymorphism with bone mineral density. Biochemical and Biophysical Research Communications 2000 269 2 537 541 10.1006/bbrc.2000.2285 2-s2.0-0034673547 (Pubitemid 30440336)
56. Lau H. H. L., Ho A. Y. Y., Luk K. D. K., Kung A. W. C., Estrogen receptor β gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women. Bone 2002 31 2 276 281 10.1016/S8756-3282(02)00827-X 2-s2.0-0036021054 (Pubitemid 34814961)
57. Scariano J. K., Simplicio S. G., Montoya G. D., Garry P. J., Baumgartner R. N., Estrogen receptor β dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women. Calcified Tissue International 2004 74 6 501 508 10.1007/s00223-003-0170-x 2-s2.0-2942633601 (Pubitemid 38780285)
58. Barrett-Connor E., Sex differences in coronary heart disease: why are women so superior? The 1995 Ancel Keys Lecture. Circulation 1997 95 1 252 264 2-s2.0-0031024219 (Pubitemid 27029969)
59. Lu H., Higashikata T., Inazu A., Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 817 823
60. Pollak A., Rokach A., Blumenfeld A., Rosen L. J., Resnik L., Pollak R. D., Association of oestrogen receptor alpha gene polymorphism with the angiographic extent of coronary artery disease. European Heart Journal 2004 25 3 240 245 10.1016/j.ehj.2003.10.028 2-s2.0-1242272036 (Pubitemid 38235161)
61. Alevizaki M., Saltiki K., Cimponeriu A., Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor a polymorphic variants. European Journal of Endocrinology 2007 156 4 489 496 10.1530/EJE-06-0685 2-s2.0-34247636067 (Pubitemid 46672651)
62. Grant S. F. A., Reid D. M., Blake G., Herd R., Fogelman I., Ralston S. H., Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I a 1 gene. Nature Genetics 1996 14 2 203 205 10.1038/ng1096-203 2-s2.0-0029836744 (Pubitemid 26338805)
63. Uitterlinden A. G., Burger H., Huang Q., Relation of alleles of the collagen type Ia1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. The New England Journal of Medicine 1998 338 15 1016 1021 10.1056/NEJM199804093381502 2-s2.0-17944404767 (Pubitemid 28180402)
64. Harris S. S., Patel M. S., Cole D. E. C., Dawson-Hughes B., Associations of the collagen type Ia1 Sp1 polymorphism with five-year rates of bone loss in older adults. Calcified Tissue International 2000 66 4 268 271 10.1007/s002230010054 2-s2.0-0034016471 (Pubitemid 30151799)
65. MacDonald H. M., McGuigan F. A., New S. A., COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss. Journal of Bone and Mineral Research 2001 16 9 1634 1641 2-s2.0-0031666593 (Pubitemid 32786432)
66. Qureshi A. M., McGuigan F. E. A., Seymour D. G., Hutchison J. D., Reid D. M., Ralston S. H., Association between COLIA1 Sp1 alleles and femoral neck geometry. Calcified Tissue International 2001 69 2 67 72 2-s2.0-0033838929 10.1007/s002230010037 (Pubitemid 32762906)
67. Stewart T. L., Roschger P., Misof B. M., Association of COLIA1 Sp1 alleles with defective bone nodule formation in vitro and abnormal bone mineralization in vivo. Calcified Tissue International 2005 77 2 113 118 2-s2.0-2342655818 10.1007/s00223-004-0188-8 (Pubitemid 41507199)
68. Mann V., Hobson E. E., Li B., A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. Journal of Clinical Investigation 2001 107 7 899 907 2-s2.0-17644445505 (Pubitemid 32274043)
69. Mann V., Ralston S. H., s.ralston@abdn.ac.uk Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 2003 32 6 711 717 2-s2.0-0343986447 10.1016/S8756-3282(03)00087-5 (Pubitemid 37297394)
70. Ralston S. H., Uitterlinden A. G., Brandi M. L., Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Medicine 2006 3 4, article e90 515 523 2-s2.0-18144402061 10.1371/journal.pmed.0030090
71. Bonewald L. F., Mundy G. R., Role of transforming growth factor-beta in bone remodeling. Clinical Orthopaedics and Related Research 1990 250 261 276 2-s2.0-0025061136 (Pubitemid 20033993)
72. Pfeilschifter J., DSouza S. M., Mundy G. R., Effects of transforming growth factor- β on osteoblastic osteosarcoma cells. Endocrinology 1987 121 1 212 218 2-s2.0-0023261189 (Pubitemid 17089281)
73. Chenu C., Pfeilschifter J., Mundy G. R., Roodman G. D., Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proceedings of the National Academy of Sciences of the United States of America 1988 85 15 5683 5687 2-s2.0-1542792344
74. Langdahl B. L., Knudsen J. Y., Jensen H. K., Gregersen N., Eriksen E. F., A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997 20 3 289 294 10.1016/S8756-3282(96)00363-8 2-s2.0-0030999773 (Pubitemid 27141842)
75. Yamada Y., Miyauchi A., Takagi Y., Tanaka M., Mizuno M., Harada A., Association of the C509→T polymorphism, alone or in combination with the T869→C polymorphism, of the transforming growth factor- β1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. Journal of Molecular Medicine 2001 79 2 149 156 2-s2.0-0035075306 (Pubitemid 32285341)
76. Yamada Y., Miyauchi A., Goto J., Association of a polymorphism of the transforming growth factor- β 1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. Journal of Bone and Mineral Research 1998 13 10 1569 1576 10.1359/jbmr.1998.13.10.1569 2-s2.0-0031667368 (Pubitemid 28465297)
77. Yamada Y., Ando F., Niino N., Shimokata H., Transforming growth factor- β 1 gene polymorphism and bone mineral density. Journal of the American Medical Association 2001 285 2 167 168 2-s2.0-0035835078 (Pubitemid 32048514)
78. Yamada Y., Association of polymorphisms of the transforming growth factor- β 1 gene with genetic susceptibility to osteoporosis. Pharmacogenetics 2001 11 9 765 771 10.1097/00008571-200112000-00004 2-s2.0-0035216206 (Pubitemid 33151511)
79. Yamada Y., Association of a Leu10→Pro polymorphism of the transforming growth factor- β 1 with genetic susceptibility to osteoporosis and spinal osteoarthritis. Mechanisms of Ageing and Development 2000 116 2-3 113 123 10.1016/S0047-6374(00)00131-7 2-s2.0-0034738172
80. Yamada Y., Hosoi T., Makimoto F., Tanaka H., Seino Y., Ikeda K., Transforming growth factor beta-1 gene polymorphism and bone mineral density in Japanese adolescents. American Journal of Medicine 1999 106 4 477 479 10.1016/S0002-9343(99)00043-1 2-s2.0-0033119209 (Pubitemid 29190603)
81. Langdahl B. L., Uitterlinden A. G., Ralston S. H., Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone 2008 42 5 969 981 10.1016/j.bone.2007.11.007 2-s2.0-41949128499
82. Grainger D. J., Metcalfe J. C., A pivotal role for TGF- β in atherogenesis? Biological Reviews of the Cambridge Philosophical Society 1995 70 4 571 596 2-s2.0-0028972852
83. Grainger D. J., Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 3 399 404 10.1161/01.ATV.0000114567. 76772.33 2-s2.0-1542313954 (Pubitemid 38326130)
84. Metcalfe J. C., Grainger D. J., Transforming growth factor- β and the protection from cardiovascular injury hypothesis. Biochemical Society Transactions 1995 23 2 403 406 2-s2.0-0029070665
85. Saltis J., Agrotis A., Bobik A., Regulation and interactions of transforming growth factor- β with cardiovascular cells: implications for development and disease. Clinical and Experimental Pharmacology and Physiology 1996 23 3 193 200 2-s2.0-0029938333 (Pubitemid 26167427)
86. Nikol S., Isner J. M., Pickering J. G., Kearney M., Leclerc G., Weir L., Expression of transforming growth factor- β 1 is increased in human vascular restenosis lesions. Journal of Clinical Investigation 1992 90 4 1582 1592 2-s2.0-0026450848
87. Wang X. L., Liu S.-X., Wilcken D. E. L., Circulating transforming growth factor β 1 and coronary artery disease. Cardiovascular Research 1997 34 2 404 410 10.1016/S0008-6363(97)00033-3 2-s2.0-0030994625 (Pubitemid 27241586)
88. Ivanov V. P., Solodilova M. A., Polonnikov A. V., Arg25Pro polymorphism of transforming growth factor- β 1 and its role in the pathogenesis of essential hypertension in Russian population of the Central Chernozem Region. Bulletin of Experimental Biology and Medicine 2007 144 1 66 68 10.1007/s10517-007-0256-y 2-s2.0-36349000570 (Pubitemid 350142489)
89. Lijnen P. J., Petrov V. V., Fagard R. H., Association between transforming growth factor- β and hypertension. American Journal of Hypertension 2003 16 7 604 611 10.1016/S0895-7061(03)00847-1 2-s2.0-0038235848 (Pubitemid 36829713)
90. Cambien F., Ricard S., Troesch A., Polymorphisms of the transforming growth factor- β 1 gene in relation to myocardial infarction and blood pressure: the etude cas-temoin de linfarctus du myocarde (ECTIM) study. Hypertension 1996 28 5 881 887 2-s2.0-10344243008 (Pubitemid 26365534)
91. Sie M. P. S., Uitterlinden A. G., Bos M. J., TGF- β 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam study. Stroke 2006 37 11 2667 2671 10.1161/01.STR.0000244779.30070.1a 2-s2.0-33750964898 (Pubitemid 44922523)
92. Syrris P., Carter N. D., Metcalfe J. C., Transforming growth factor- β 1 gene polymorphisms and coronary artery disease. Clinical Science 1998 95 6 659 667 10.1042/CS19980154 2-s2.0-0032426616 (Pubitemid 29034430)
93. Wang X. L., Sim A. S., Wilcken D. E. L., A common polymorphism of the transforming growth factor- β 1 gene and coronary artery disease. Clinical Science 1998 95 6 745 746 10.1042/CS19980292 2-s2.0-0032442094 (Pubitemid 29034440)
94. Yokota M., Ichihara S., Lin T.-L., Nakashima N., Yamada Y., Association of a T29→C polymorphism of the transforming growth factor- β 1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000 101 24 2783 2787 2-s2.0-0034690805 (Pubitemid 30396007)
95. Argano C., Duro G., Corrao S., Transforming growth factor β 1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage. Blood Pressure 2008 17 4 220 226 10.1080/08037050802431416 2-s2.0-58949104700
96. Gong Y., Slee R. B., Fukai N., LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001 107 4 513 523 10.1016/S0092-8674(01)00571-2 2-s2.0-18044386744 (Pubitemid 33152786)
97. Boyden L. M., Mao J., Belsky J., High bone density due to a mutation in LDL-receptor-related protein 5. The New England Journal of Medicine 2002 346 20 1513 1521 10.1056/NEJMoa013444 2-s2.0-0037118285 (Pubitemid 34755690)
98. Little R. D., Carulli J. P., Del Mastro R. G., A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. American Journal of Human Genetics 2002 70 1 11 19 10.1086/338450 2-s2.0-0036138175 (Pubitemid 34031693)
99. Kokubu C., Heinzmann U., Kokubu T., Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis. Development 2004 131 21 5469 5480 10.1242/dev.01405 2-s2.0-9444235153 (Pubitemid 39562189)
100. Ferrari S. L., serge.ferrari@medecine.unige.ch Deutsch S., Choudhury U., Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. American Journal of Human Genetics 2004 74 5 866 875 2-s2.0-0032406715 10.1086/420771 (Pubitemid 38568961)
101. Mizuguchi T., Furuta I., Watanabe Y., LRP5, low-density-lipoprotein- receptor-related protein 5, is a determinant for bone mineral density. Journal of Human Genetics 2004 49 2 80 86 10.1007/s10038-003-0111-6 2-s2.0-12144287023 (Pubitemid 38405069)
102. van Meurs J. B. J., Rivadeneira F., Jhamai M., Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. Journal of Bone and Mineral Research 2006 21 1 141 150 10.1359/JBMR.050904 2-s2.0-29644446220 (Pubitemid 43023236)
103. van Meurs J. B. J., Trikalinos T. A., Ralston S. H., Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. Journal of the American Medical Association 2008 299 11 1277 1290 10.1001/jama.299.11.1277 2-s2.0-40949146531 (Pubitemid 351439074)
104. Masi L., Becherini L., Gennari L., Polymorphism of the aromatase gene in postmenopausal italian women: distribution and correlation with bone mass and fracture risk. Journal of Clinical Endocrinology and Metabolism 2001 86 5 2263 2269 10.1210/jc.86.5.2263 2-s2.0-17744379150 (Pubitemid 32472950)
105. Shimodaira M., Nakayama T., Sato N., Association study of aromatase gene (CYP19A1) in essential hypertension. International Journal of Medical Sciences 2008 5 1 29 35 2-s2.0-39449117689 (Pubitemid 351270279)
106. Ramirez-Lorca R., Grilo A., Martinez-Larrad M. T., Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants. Hypertension 2007 50 5 884 890 10.1161/HYPERTENSIONAHA.107.096263 2-s2.0-35848939163 (Pubitemid 350287530)
107. Letonja M., Peterlin B., Bregar D., Petrovic D., Are the T/C polymorphism of the CYP17 gene and the tetranucleotide repeat (TTTA) polymorphism of the CYP19 gene genetic markers for premature coronary artery disease in Caucasians? Folia Biologica 2005 51 3 76 81 2-s2.0-22144438306 (Pubitemid 40975643)
108. Kim J. G., Roh K. R., Lee J. Y., The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism, and bone mineral density in postmenopausal women in Korea. American Journal of Obstetrics and Gynecology 2002 186 3 345 350 10.1067/mob.2002.120483 2-s2.0-0036128146 (Pubitemid 34234139)
109. Rosen C. J., Kurland E. S., Vereault D., Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. Journal of Clinical Endocrinology and Metabolism 1998 83 7 2286 2290 10.1210/jc.83.7.2286 2-s2.0-0031759897 (Pubitemid 28503015)
110. Rivadeneira F., Houwing-Duistermaat J. J., Vaessen N., Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: the Rotterdam Study. Journal of Clinical Endocrinology and Metabolism 2003 88 8 3878 3884 (Pubitemid 37034542)
111. Miyao M., Hosoi T., Inoue S., Polymorphism of insulin-like growth factor I gene and bone mineral density. Calcified Tissue International 1998 63 4 306 311 10.1007/s002239900532 2-s2.0-0031687612 (Pubitemid 28443414)
112. Jiang D.-K., Shen H., Li M.-X., No major effect of the insulin-like growth factor I gene on bone mineral density in premenopausal Chinese women. Bone 2005 36 4 694 699 10.1016/j.bone.2005.01.013 2-s2.0-20944437651 (Pubitemid 40602263)
113. Takacs I., Koller D. L., Peacock M., Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus. Journal of Clinical Endocrinology and Metabolism 1999 84 12 4467 4471 2-s2.0-0026719876
114. Scheidt-Nave C., Bismar H., Leidig-Bruckner G., Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. Journal of Clinical Endocrinology and Metabolism 2001 86 5 2032 2042 10.1210/jc.86.5.2032 2-s2.0-0034997713 (Pubitemid 32472916)
115. Tsukamoto K., Yoshida H., Watanabe S., Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenoposal Japanese women. Journal of Human Genetics 1999 44 3 148 151 10.1007/s100380050132 2-s2.0-0032951341 (Pubitemid 29219898)
116. Murray R. E., Mcguigan F., Grant S. F. A., Reid D. M., Ralston S. H., Polymorphisms of the Interleukin-6 gene are associated with bone mineral density. Bone 1997 21 1 89 92 10.1016/S8756-3282(97)00081-1 2-s2.0-0030857328 (Pubitemid 27341744)
117. Ferrari S. L., Ahn-Luong L., Garnero P., Humphries S. E., Greenspan S. L., Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2003 88 1 255 259 10.1210/jc.2002-020092 2-s2.0-0037241338 (Pubitemid 36115175)
118. Ferrari S. L., Garnero P., Emond S., Montgomery H., Humphries S. E., Greenspan S. L., A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis and Rheumatism 2001 44 1 196 201 2-s2.0-0035156066 (Pubitemid 32113135)
119. Humphries S. E., Luong L. A., Ogg M. S., Hawe E., Miller G. J., The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. European Heart Journal 2001 22 24 2243 2252 10.1053/euhj.2001.2678 2-s2.0-0035661847 (Pubitemid 34000979)
120. Georges J.-L., Loukaci V., Poirier O., Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Journal of Molecular Medicine 2001 79 5-6 300 305 10.1007/s001090100209 2-s2.0-0034945885 (Pubitemid 32646387)
121. Basso F., Lowe G. D. O., Rumley A., McMahon A. D., Humphries S. E., Interleukin-6 -174 G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 4 599 604 10.1161/01.ATV.0000013283. 84306.1A 2-s2.0-0036123849 (Pubitemid 34408740)
122. Chiappelli M., Tampieri C., Tumini E., Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. International Journal of Immunogenetics 2005 32 6 349 353 10.1111/j.1744-313X.2005.00537.x 2-s2.0-28444457805 (Pubitemid 41735572)
123. Lalouschek W., Schillinger M., Hsieh K., Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clinical Chemistry and Laboratory Medicine 2006 44 8 918 923 10.1515/CCLM.2006.165 2-s2.0-33746630277 (Pubitemid 44155857)
124. Hulkkonen J., Lehtimäki T., Mononen N., Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: the Cardiovascular Risk in Young Finns Study. Atherosclerosis 2009 203 2 454 458 10.1016/j.atherosclerosis.2008.07.014 2-s2.0-62649162325
125. Balding J., Livingstone W. J., Pittock S. J., Mynett-Johnson L., Ahern T., Smith O. P., The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Irish Journal of Medical Science 2004 173 4 200 203 2-s2.0-14844302204 (Pubitemid 40347676)
126. Myśliwska J., Wieckiewicz J., Hak., Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries. European Cytokine Network 2006 17 3 181 188 2-s2.0-38849124033
127. Sie M. P. S., Sayed-Tabatabaei F. A., Oei H.-H. S., Interleukin-6 -174 G/C promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 1 212 217 10.1161/01.ATV.0000194099.65024.17 2-s2.0-33644820475 (Pubitemid 43732252)
128. Mayosi B. M., Avery P. J., Baker M., Genotype at the -174 G/C polymorphism of the interleukin-6 gene is associated with common carotid artery intimal-medial thickness: family study and meta-analysis. Stroke 2005 36 10 2215 2219 10.1161/01.STR.0000182254.47941.96 2-s2.0-26444578213 (Pubitemid 41429249)
129. Miyao M., Hosoi T., Emi M., Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus. Journal of Human Genetics 2000 45 6 346 350 2-s2.0-0033636514
130. Nakamura M., Zhang Z.-Q., Shan L., Allelic variants of human calcitonin receptor in the Japanese population. Human Genetics 1997 99 1 38 41 10.1007/s004390050307 2-s2.0-0031060676 (Pubitemid 26419852)
131. Masi L., Becherini L., Gennari L., Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women. Biochemical and Biophysical Research Communications 1998 245 2 622 626 10.1006/bbrc.1998.8445 2-s2.0-0032540159 (Pubitemid 28418555)
132. Braga V., Mottes M., Mirandola S., Association of CTR and COLIA1 alleles with BMD values in peri-and postmenopausal women. Calcified Tissue International 2000 67 5 361 366 10.1007/s002230001160 2-s2.0-0034524042 (Pubitemid 32061168)
133. Taboulet J., Frenkian M., Frendo J. L., Feingold N., Jullienne A., de Vernejoul M. C., Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women. Human Molecular Genetics 1998 7 13 2129 2133 2-s2.0-0031730801 (Pubitemid 28546423)
134. Tsukamoto K., Orimo H., Hosoi T., Association of bone mineral density with polymorphism of the human calcium-sensing receptor locus. Calcified Tissue International 2000 66 181 183 (Pubitemid 30091757)
135. Takács I., Speer G., Bajnok E., Lack of association between calcium-sensing receptor gene "A986S" polymorphism and bone mineral density in Hungarian postmenopausal women. Bone 2002 30 6 849 852 2-s2.0-0019254797 10.1016/S8756-3282(02)00741-X (Pubitemid 34616012)
136. Eckstein M., Vered I., Ish-Shalom S., Vitamin D and calcium-sensing receptor genotypes in men and premenopausal women with low bone mineral density. Israel Medical Association Journal 2002 4 5 340 344 2-s2.0-0036246325 (Pubitemid 34477003)
137. Langdahl B. L., Stenkjær L., Carstens M., Tofteng C. L., Eriksen E. F., A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures. Calcified Tissue International 2003 73 3 237 243 10.1007/s00223-002-0019-8 2-s2.0-0141857853 (Pubitemid 37152884)
138. Duncan E. L., Brown M. A., Sinsheimer J., Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. Journal of Bone and Mineral Research 1999 14 12 1993 1999 2-s2.0-0033397211 (Pubitemid 30026946)
139. Uitterlinden A. G., Arp P. P., Paeper B. W., Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. American Journal of Human Genetics 2004 75 6 1032 1045 10.1086/426458 2-s2.0-8844261126 (Pubitemid 39532072)
140. Styrkarsdottir U., Cazier J.-B., Kong A., Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biology 2003 1 3, article E69 10.1371/journal.pbio.0000069 2-s2.0-4243129131 (Pubitemid 39112134)
141. Arko B., Preželj J., Komel R., Kocijančič A., Hudler P., Marc J., Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. Journal of Clinical Endocrinology and Metabolism 2002 87 9 4080 4084 10.1210/jc.2002-020124 2-s2.0-0036736816
142. Langdahl B. L., Carstens M., Stenkjaer L., Eriksen E. F., Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. Journal of Bone and Mineral Research 2002 17 7 1245 1255 2-s2.0-0035991255 (Pubitemid 34680501)
143. Venter J. C., Adams M. D., Myers E. W., The sequence of the human genome. Science 2001 291 5507 1304 1351 10.1126/science.1058040 2-s2.0-0035895505 (Pubitemid 32173090)
144. Zhang W., Ratain M. J., Dolan M. E., The HapMap resource is providing new insights into ourselves and its application to pharmacogenomics. Bioinformatics and Biology Insights 2008 2 15 23
145. Liu Y.-J., Shen H., Xiao P., Molecular genetic studies of gene identification for osteoporosis: a 2004 update. Journal of Bone and Mineral Research 2006 21 10 1511 1535 10.1359/jbmr.051002 2-s2.0-33745612144 (Pubitemid 44484596)
146. Kiel D. P., Demissie S., Dupuis J., Lunetta K. L., Murabito J. M., Karasik D., Genome-wide association with bone mass and geometry in the framingham heart study. BMC Medical Genetics 2007 8 supplement 1, article S14 10.1186/1471-2350-8-S1-S14 2-s2.0-35748963239 (Pubitemid 351958747)
147. Arking D. E., Chakravarti A., Understanding cardiovascular disease through the lens of genome-wide association studies. Trends in Genetics 2009 25 9 387 394 10.1016/j.tig.2009.07.007 2-s2.0-69449101822
148. Cheung C.-L., Sham P. C., Chan V., Paterson A. D., Luk K. D. K., Kung A. W. C., Identification of LTBP2 on chromosome 14q as a novel candidate gene for bone mineral density variation and fracture risk association. Journal of Clinical Endocrinology and Metabolism 2008 93 11 4448 4455 10.1210/jc.2007-2836 2-s2.0-57349109503 (Pubitemid 352789546)
149. Chen X.-D., Xiao P., Lei S.-F., Gene expression profiling in monocytes and SNP association suggest the importance of the STAT1 gene for osteoporosis in both Chinese and Caucasians. Journal of Bone and Mineral Research 2010 25 2 339 355 10.1359/jbmr.090724
150. Koller D. L., Alam I., Sun Q., Genome screen for bone mineral density phenotypes in Fisher 344 and Lewis rat strains. Mammalian Genome 2005 16 8 578 586 10.1007/s00335-004-2459-0 2-s2.0-25144518633 (Pubitemid 41355920)
151. Beamer W. G., Shultz K. L., Donahue L. R., Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. Journal of Bone and Mineral Research 2001 16 7 1195 1206 2-s2.0-0033328296 (Pubitemid 32574647)
152. Klein R. F., Mitchell S. R., Phillips T. J., Belknap J. K., Orwoll E. S., Quantitative trait loci affecting peak bone mineral density in mice. Journal of Bone and Mineral Research 1998 13 11 1648 1656 10.1359/jbmr.1998.13.11.1648 2-s2.0-0031754518 (Pubitemid 28491992)
153. Havill L. M., Mahaney M. C., Cox L. A., Morin P. A., Joslyn G., Rogers J., A quantitative trait locus for normal variation in forearm bone mineral density in pedigreed baboons maps to the ortholog of human chromosome 11q. Journal of Clinical Endocrinology and Metabolism 2005 90 6 3638 3645 10.1210/jc.2004-1618 2-s2.0-21244476827 (Pubitemid 41014337)
154. Klein R. F., Allard J., Avnur Z., Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 2004 303 5655 229 232 10.1126/science.1090985 2-s2.0-9144272249 (Pubitemid 38057572)
155. Ichikawa S., Koller D. L., Johnson M. L., Human ALOX12, but not ALOX15, is associated with BMD in white men and women. Journal of Bone and Mineral Research 2006 21 4 556 564 10.1359/jbmr.051212 2-s2.0-33645337659
156. Mullin B. H., Spector T. D., Curtis C. C., Polymorphisms in ALOX12, but not ALOX15, are significantly associated with BMD in postmenopausal women. Calcified Tissue International 2007 81 1 10 17 10.1007/s00223-007-9023-3 2-s2.0-34447097190 (Pubitemid 47030201)
157. Marini F., Brandi M. L., Pharmacogenetics of osteoporosis: future perspectives. Calcified Tissue International 2009 84 5 337 347 10.1007/s00223-009-9226-x 2-s2.0-67349094884
158. Marini F., Falchetti A., Silvestri S., Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis. Current Medical Research and Opinion 2008 24 9 2609 2615 10.1185/03007990802352894 2-s2.0-53349101679